Helmholtz Centre for Infection Research   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Braunschweig Germany (1965)

Organization Overview

First Clinical Trial
2014
NCT03361878
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany | Helmholtz Zentrum München